NES
BRLI

New England Securities’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

New England Securities’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-199
Closed -$6K – 1787
2013
Q3 		$6K Hold
199
– – ﹤0.01% 1148
2013
Q2 		$6K Buy
+199
New +$5.48K ﹤0.01% 1026

Other funds holding BRLI

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CM
CS McKee Pittsburgh, Pennsylvania $1.09B AUM 31.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

New England Securities's BRLI Position: Q4 2013 in Review

New England Securities sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q4 2013, closing a stake of 199 shares — an estimated $6K sold.

New England Securities first reported a position in BRLI in Q2 2013 and held it in 2 quarters. The position peaked at $6K in Q3 2013. 175 funds tracked by Wall St. Rank hold BRLI as of Q4 2013.

  • New England Securities reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q4 2013 after selling out during the quarter.
  • New England Securities sold 199 BIO-REFERENCE LABS INC-NEW- shares in Q4 2013, an estimated $6K.
  • New England Securities first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 2 quarters.
  • New England Securities's BIO-REFERENCE LABS INC-NEW- position peaked at $6K in Q3 2013.
  • 175 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q4 2013.

Based on New England Securities's 13F filing for Q4 2013, filed 31 Jan 2014.